Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
about
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasTargeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.CD44-mediated activation of α5β1-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices.Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.Xtalk: a path-based approach for identifying crosstalk between signaling pathwaysRegulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.Discovery of genes from feces correlated with colorectal cancer progressionMelatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathwayTransposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of YapThe Hippo pathway member YAP enhances human neural crest cell fate and migration.Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.Low-after-high glucose down-regulated Cx43 in H9c2 cells by autophagy activation via cross-regulation by the PI3K/Akt/mTOR and MEK/ERK1/2 signal pathways.The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway.P2Y2 Nucleotide Receptor Prompts Human Cardiac Progenitor Cell Activation by Modulating Hippo Signaling.Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
P2860
Q26782842-76CC8100-3507-42F4-BB28-6DD05679471AQ33703311-BD35998A-A55A-495F-B554-88476564CDA6Q36229809-928819D3-D15A-4EAA-BA20-E553BE61B5DCQ36546783-33F85D6D-9701-44B2-85DE-8B87DB2D2629Q36962804-A0D75602-BBFC-47BB-9DCF-15D564C56E31Q37002991-4613E7B2-A11C-428D-AE22-8F1D1ED87C50Q37098317-776FE717-7006-411A-9A5B-363A6B97EABAQ37406961-C700D7F8-BAF8-4833-9C25-C782F2551E9EQ37465949-CE305E8A-E17E-4A63-8904-C8E8544DA9F9Q37711615-55E17CE9-3707-424D-9B10-70D71408FEA5Q37725431-E22DB438-2A3C-437A-907B-8C3D738DE071Q38679866-38ED2EBD-0627-4258-9791-39535AB01C5CQ38786060-B285E98B-2F94-4869-AC7D-6A030B18FFA0Q41354217-CC2F5CE5-6CB8-4BAF-9FD9-7101A02E5C83Q41913416-98B705D9-924D-4A86-A727-1981A22FF037Q47123455-7437DA10-AC86-4D86-ADCE-A61DEFAFAC93Q47153821-66B4B60C-466C-404F-86D6-910718CDB865Q47661844-EB04FD42-6EEF-4740-91D7-05A5D7661035Q58788865-07268DDD-07BD-42C9-855D-252D22A28804
P2860
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@ast
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@en
type
label
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@ast
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@en
prefLabel
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@ast
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@en
P2093
P2860
P356
P1433
P1476
Adhesion glycoprotein CD44 fun ...... pathways in cancer progression
@en
P2093
Jean Paul Thiery
Liming Chen
Xiuxiu Cai
Yuzhi Wang
P2860
P304
P356
10.18632/ONCOTARGET.3095
P407
P577
2015-02-01T00:00:00Z